Novel mechanistic concepts for the control of leukocyte transmigration: specialization of integrins, chemokines, and junctional molecules

被引:132
作者
Weber, C [1 ]
机构
[1] Univ Klinikum Aachen, D-52074 Aachen, Germany
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 2003年 / 81卷 / 01期
关键词
Integrins; chemokines; junctional adhesion molecule; leukocyte; emigration; inflammation;
D O I
10.1007/s00109-002-0391-x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The emigration of leukocytes from the circulation is a critical step during immune surveillance and inflammatory reactions and is governed by a coordinated interplay involving a spectrum of adhesion and signal molecules. As the original multistep model of leukocyte trafficking undergoes continuous revision and refinement, the identification of additional molecules and the emergence of novel concepts for their intricately overlapping functions indicate that this process is still not completely understood. Early studies defining the multistep model described the rapid transition of selectin-mediated leukocyte rolling into integrin-dependent arrest followed by transendothelial diapedesis. It has become apparent that highly specialized chemoattractive cytokines termed chemokines and their heptahelical receptors are involved in the emigration of leukocytes not only by inducing chemotaxis but also by regulating integrins to trigger cell arrest in shear flow. In light of the enormously pleiotropic role of integrins and chemokines in vertebrate biology, this review summarizes and highlights selected aspects of currently evolving concepts refining the multistep model: (a) the differential activation of integrin avidity by chemokines and its implications, (b) the functional specialization of chemokines and their receptors in leukocyte recruitment, and (c) the multilayered molecular "zipper" controlling the completion of diapedesis at interendothelial junctions.
引用
收藏
页码:4 / 19
页数:16
相关论文
共 126 条
  • [1] Monocytes induce reversible focal changes in vascular endothelial cadherin complex during transendothelial migration under flow
    Allport, JR
    Muller, WA
    Luscinskas, FW
    [J]. JOURNAL OF CELL BIOLOGY, 2000, 148 (01) : 203 - 216
  • [2] Histamine induces tyrosine phosphorylation of endothelial cell-to-cell adherens junctions
    Andriopoulou, P
    Navarro, P
    Zanetti, A
    Lampugnani, MG
    Dejana, E
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (10) : 2286 - 2297
  • [3] The last molecular fortress in leukocyte trans-endothelial migration
    Aurrand-Lions, M
    Johnson-Leger, C
    Imhof, BA
    [J]. NATURE IMMUNOLOGY, 2002, 3 (02) : 116 - 118
  • [4] RAPID G-PROTEIN-REGULATED ACTIVATION EVENT INVOLVED IN LYMPHOCYTE BINDING TO HIGH ENDOTHELIAL VENULES
    BARGATZE, RF
    BUTCHER, EC
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (01) : 367 - 372
  • [5] A new class of membrane-bound chemokine with a CX(3)C motif
    Bazan, JF
    Bacon, KB
    Hardiman, G
    Wang, W
    Soo, K
    Rossi, D
    Greaves, DR
    Zlotnik, A
    Schall, TJ
    [J]. NATURE, 1997, 385 (6617) : 640 - 644
  • [6] Hemophilic interaction of junctional adhesion molecule
    Bazzoni, G
    Martìnez-Estrada, OM
    Mueller, F
    Nelboeck, P
    Schmid, G
    Bartfai, T
    Dejana, E
    Brockhaus, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (40) : 30970 - 30976
  • [7] Through and beyond the wall: late steps in leukocyte transendothelial migration
    Bianchi, E
    Bender, JR
    Blasi, F
    Pardi, R
    [J]. IMMUNOLOGY TODAY, 1997, 18 (12): : 586 - 591
  • [8] A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice
    Boisvert, WA
    Santiago, R
    Curtiss, LK
    Terkeltaub, RA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) : 353 - 363
  • [9] Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis
    Boring, L
    Gosling, J
    Cleary, M
    Charo, IF
    [J]. NATURE, 1998, 394 (6696) : 894 - 897
  • [10] Burns AR, 1997, J IMMUNOL, V159, P2893